Application of eIF3I-PDL1-IRS4 axis in preparation of medicine for treating refractory ulcer
A refractory ulcer, 1. PDL1 technology, applied in the field of biomedicine, to achieve the effect of overcoming proliferation and migration, good epithelialization, and reducing inflammation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0063] 1. Methods and materials
[0064] 1. Clinical samples
[0065] Clinical samples were provided by patients with written informed consent, and were approved by the Ethics Committee of Yueyang Hospital ( Figure 25 ). All patients underwent surgical treatment in surgery from April 2019 to February 2020. DU samples were collected from the margins of unhealed wounds during surgical debridement, and normal skin samples were collected from excess skin collected during cosmetic surgery. Immediately after the tissue was cut, it was fixed with 70% formalin and embedded in paraffin. The clinical characteristics of the patients are shown in Table 1.
[0066] Table 1 Clinical patient characteristics
[0067]
[0068] 2. Cell culture and transfection
[0069] The human keratinocyte cell line HaCaT was purchased from Cell Lines Service, Eppelheim, Germany. Cells were cultured in DMEM-high glucose (4.5 g / L, Gibco, Life Technologies, Carlsbad, CA) containing 10% (v / v) fetal bo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com